BGDV Bahl & Gaynor Dividend ETF

Expense Ratio
0.45%
Dividend
1.02%
Previous close
$27.63
Est. 12 months change
+16.29%
Projected Price
$32.13

Profitability Metrics

Return on Equity (ROE)
33.66%
Return on Assets (ROA)
9.32%
Return on Invested Capital (ROIC)
19.72%
Weighted Average Cost of Capital (WACC)
8.20%
ROIC - WACC
11.52%
Updated : 2026-04-03 21:50 ET

Valuation Metrics

P/E Ratio
25.82
Forward P/E
19.50
PEG Ratio
2.17
Debt Current Ratio
1.49

Growth & Cash Flow

Gross Margin
49.21%
Operating Margin
27.50%
FCF Margin
18.83%
TTM Revenue Growth
16.39%
Projected 12M EPS Growth
32.39%

Price Change

Price % from 50 SMA
-2.71%
Price % from 200 SMA
2.26%
6 Months
2.22%
1 Year
13.65%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
TSM5.42%
AVGO4.80%
MSI4.01%
LLY3.89%
TJX3.23%
TRGP3.23%
WMB3.06%
ABBV3.05%
GOOGL2.89%
WDC2.78%

ETF Analysis

Fund Overview

Bahl & Gaynor Dividend ETF (BGDV) currently reports 49 stock positions (subject to change), placing it in the moderately broad range by holdings breadth. The top line-up is TSM (5.42%), AVGO (4.80%), MSI (4.01%), with TSM as the largest single weight at 5.42%. Together, the top three holdings account for 14.23%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.

Profitability & Capital Efficiency

Looking at how effectively the underlying holdings deploy capital, ROIC is 19.72%, WACC is 8.20%, and the economic spread is 11.52%. On balance, returns on invested capital exceed the cost of funding by a comfortable margin, which over time compounds favorably for long-term holders. Supporting metrics show ROE at 33.66% and ROA at 9.32%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

From a pricing standpoint, the portfolio sits at trailing P/E of 25.82, forward P/E of 19.50, PEG of 2.17. The gap between trailing and forward multiples is meaningful but not wide — the market appears to be pricing a constructive but controlled earnings trajectory. The growth-adjusted multiple is neither a strong buy signal nor a clear warning — it sits in the range where execution quality will determine whether the price is ultimately justified. A current ratio reading of 1.49 suggests the portfolio's holdings carry less short-term financial cushion than the broader market average. In total, the multiple and liquidity readings describe a portfolio where valuation is a secondary risk relative to earnings delivery — the numbers are defensible if estimates hold.

Margins & Cash Generation

Across the three margin layers, gross margin sits at 49.21%, operating margin at 27.50%, and free cash flow margin at 18.83%. Gross margins sit in a healthy range, consistent with businesses that manage input costs effectively. Operating margins are in good shape, consistent with businesses that maintain reasonable earnings conversion after overhead. At this level, free cash flow margins suggest businesses that are building financial strength alongside revenue growth. Read together, these margin levels suggest a portfolio where earnings durability is present in parts but not consistent across the full holding set.

Growth & Forward Outlook

On a forward-looking basis, TTM revenue growth of 16.39% a signal of steady demand without the volatility of high-growth names, while the estimated 12-month price change of 16.45%, where the target distribution indicates incremental upside rather than outsized repricing. Revenue growth and price targets are correlated but not the same — strong operations do not always translate to strong price appreciation, and vice versa. The forward return case rests on whether the businesses can sustain their operating trajectory long enough for analyst price targets to be reached or exceeded. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The full scorecard here is hard to argue with: capital efficiency is strong, margins are healthy, and growth is being priced constructively.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.